Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kusama

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
CPT: Pharmacometrics & Systems Pharmacology|September 18, 2015
Organ Impairment-Drug-Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of DrugsC K Yeung, K Yoshida, M Kusama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancerS Ohnoa, M Toi, K Kuroi, et al.
Oncology|September 10, 1998
A case control study on risk factors involved in inflammatory breast recurrence after breast-conserving surgeryR Nishimura, H Koyama, F Kasumi, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
CPT: Pharmacometrics & Systems Pharmacology|September 18, 2015
Organ Impairment-Drug-Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of DrugsC K Yeung, K Yoshida, M Kusama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancerS Ohnoa, M Toi, K Kuroi, et al.
Oncology|September 10, 1998
A case control study on risk factors involved in inflammatory breast recurrence after breast-conserving surgeryR Nishimura, H Koyama, F Kasumi, et al.
Pageof 8